BeiGene plots to fur­ther build its man­u­fac­tur­ing mus­cle out­side of Chi­na

9 months ago
China
Manufacturing

Pfiz­er touts Phase 3 gene ther­a­py da­ta in he­mo­phil­ia A, but now it needs to prove it can win the mar­ket

9 months ago
R&D

Sage's es­sen­tial tremor drug fails in an­oth­er blow to pipeline, Bio­gen part­ner­ship

9 months ago
R&D

Chi­nese biotech de­vel­op­ing semaglu­tide biosim­i­lar files for Hong Kong IPO

9 months ago
Financing
China

With new mis­sion in psy­chi­a­try, Au­to­bahn rais­es $100M to help back Phase 2 work

9 months ago
Financing

Ac­tivist in­vestor calls for board shake­up at As­ser­tio, threat­ens proxy con­test

9 months ago
Pharma

Ex­clu­sive: RA Cap­i­tal in­vests $35M in UK can­cer biotech Cell­Cen­tric

9 months ago
Financing
R&D

As­traZeneca signs pre­clin­i­cal EGFR drug deal with an­ti­body biotech

9 months ago
Deals
R&D

PBM ex­ec­u­tives dodge grilling in House com­mit­tee hear­ing

9 months ago
Pharma
Law

FDA asks ad­comm if As­traZeneca needs an­oth­er study on Imfinzi be­fore and af­ter lung can­cer surgery

9 months ago
Pharma
FDA+

Ab­b­Vie files law­suit in Mis­souri fed­er­al court over 340B con­tract phar­ma­cies

9 months ago
Pharma
Law

What's changed about rare dis­ease med­i­cine

9 months ago
R&D

In­di­an man­u­fac­tur­er Bras­si­ca hit with warn­ing let­ter af­ter em­ploy­ees faked da­ta re­sults

9 months ago
FDA+
Manufacturing

Up­dat­ed: Mer­ck, with­out shar­ing de­tails, says RSV an­ti­body suc­cess­ful­ly pro­tect­ed in­fants

9 months ago
R&D
Pharma

Pfiz­er lifts cur­tain on $740M+ ex­ten­sion at API man­u­fac­tur­ing site in Sin­ga­pore

9 months ago
Pharma
Manufacturing

Cel­lec­tar to seek ap­proval for ra­dioac­tive io­dine-based ther­a­py in rare blood can­cer

9 months ago
R&D

Neu­rol­o­gy start­up from Or­biMed col­lab nabs $65M in Se­ries A

9 months ago
Financing
Startups

Telix's $397M con­vert­ible bond of­fer­ing; Scynex­is records a $10M mile­stone

9 months ago
News Briefing

The obe­si­ty drug race is be­ing fought on the man­u­fac­tur­ing floor as GLP-1 ri­vals make plans to catch lead­ers

9 months ago
Pharma
In Focus

Bob Langer, Flag­ship's Stephen Beren­son to de­part Mod­er­na's board as Car­lyle co-founder joins

9 months ago
People

At Third Arc Bio, for­mer J&J lead­ers raise $165M to test on­col­o­gy, au­toim­mune bi­o­log­ics

9 months ago
Financing
Startups

Flag­ship launch­es AI-pow­ered bi­o­log­ics biotech with $50M back­ing

9 months ago
Financing
Startups

GSK says Dova­to was as ef­fec­tive as Bik­tarvy in head-to-head HIV tri­al — but pa­tients gained less weight

9 months ago
R&D

Health tech start­up Com­mure bets on AI for med­ical notes in $139M deal

9 months ago
Startups
Deals
First page Previous page 119120121122123124125 Next page Last page
A service from the Financial Times